key: cord-311635-hf6vrbyx authors: Reuken, Philipp Alexander; Rauchfuss, Falk; Albers, Stefanie; Settmacher, Utz; Trautwein, Christian; Bruns, Tony; Stallmach, Andreas title: Between Fear and Courage: Attitudes, Beliefs, and Behavior of Liver Transplantation Recipients and Waiting List Candidates during the COVID‐19 Pandemic date: 2020-06-08 journal: Am J Transplant DOI: 10.1111/ajt.16118 sha: doc_id: 311635 cord_uid: hf6vrbyx Patients with chronic liver disease and patients after solid organ transplantation (SOT) are vulnerable to severe Coronavirus Disease 2019 (COVID‐19). We evaluated fears, attitudes, and opinions associated with COVID‐19 in 365 SOT recipients (95% liver, 5% pancreas/kidney), 112 SOT candidates, and 394 immediate household contacts in two German transplant centers. Seven (1.5%) patients and 10 (2.5%) controls had contact to confirmed COVID‐19 cases. Fear of infection with SARS‐CoV‐2 was expressed by 65% SOT recipients and by 55% SOT candidates. SOT recipients had higher levels of fear of infection and more often wore personal protective gear than household controls. Female gender, steroid treatment, and using the local newspaper as a primary source of information were independently associated with expressed fear of infection in SOT recipients. Younger age and more recent transplantation correlated with concerns of severe COVID‐19 expressed by patients and with concerns of worse medical care expressed by household controls. One third of the patients expressed fear that immunosuppression could worsen COVID‐19 but only 15% used the transplantation center as a source of information. These data show that fears associated with the SARS‐CoV‐2 pandemic are frequently expressed but measures to prevent infection are frequently followed patients before and after SOT. In December 2019, a new form of severe acute respiratory syndrome (SARS) was described in Wuhan, China, and eventually a new coronavirus (SARS-CoV-2) was discovered as the causative pathogen. 1 In March 2020, after a worldwide spread SARS-CoV-2 was announced a global pandemic by the world health organization (WHO). 2 In the following weeks, more than 4.5 million people became infected and more than 300,000 people died following an infection with SARS-CoV-2. 3 Governments in different countries have responded with varying levels of social restrictions ranging from bans of assembly to complete lockdowns. 4 The coronavirus disease 2019 (COVID-19) presents with cough, fever, myalgia, headache and can cause respiratory failure with the need for mechanical ventilation, hemodialysis, extra-corporal perfusion techniques and significant mortality. 5 Although the majority of patients present with a mild or even asymptomatic course of the infection 6 , patients with obesity and existing cardiovascular and pulmonary comorbidities are reported to be at a higher risk for a severe disease course. 7 Patients with chronic liver disease and liver transplant recipients represent vulnerable patient cohorts at increased risk of bacterial, fungal, and viral infection. Although there are reports that patients with non-alcoholic fatty liver disease (NAFLD) are at higher risk for a progressive course of COVID-19 8 , until now it remains unclear to what extent chronic liver disease should be considered a risk factor for SARS-CoV-2 infection and complicated courses of COVID-19 9, 10 . Whether medical immunosuppression or pre-existing comorbidities contribute to COVID-19related mortality after liver transplantation is currently subject of debate. 11, 12 Reflecting on past SARS-CoV and the MERS-CoV outbreaks, there is no conclusive evidence that immunosuppression in patients after solid organ transplantation (SOT) is associated with poor outcome. 13 Thus, the reduction of immunosuppression is not recommended in patients with autoimmune liver disease and after liver transplantation. 14, 15 Despite such recommendation, the uncertainty regarding the COVID-19 risk after liver transplantation and on the waiting list is evident from our experience in outpatient clinics. However, to date, there is little known about how the COVID-19 pandemic has affected behavior This article is protected by copyright. All rights reserved and daily lives patients before and after liver transplantation. Thus, we assessed COVID-19 prevalence/exposure, perception, compliance and behavior of transplant recipients and candidates on the waiting list in two German liver transplant centers in April 2020 using a crosssectional anonymous survey in patients and their household members. Patients who underwent liver or pancreas/kidney transplantation or candidates on the waiting list were identified in two German transplant centers, Jena University Hospital (JUH), Thuringia, and Aachen University Hospital (AUH), North-Rhine-Westphalia. A self-report questionnaire was designed and sent to patients by mail between April 14 th and April 21 st . The study was conducted according to the Declaration of Helsinki. It was approved by the local ethics committees (2020-1733-Reg; EK121/20) and patients provided written informed consent. Only questionnaires returned until 30 th April 2020 were considered for analysis. The survey consisted of demographic data (age, sex, educational status, profession), preexisting medical conditions including transplantation status (year of transplantation, waiting list status), current immunosuppressive therapy after transplantation, flu vaccination status, and smoking status. Participants were asked to select their two most important information sources concerning the Coronavirus out of 10 options. The participants were asked 12 items their fears of being infected with SARS-CoV-2 and changes in their behavior using a 5-point Likert scale. They were also surveyed regarding their infection status, adherence to medication, personal protection equipment (e.g. facemasks covering mouth and nose and gloves in Germany) and contacts to their physician. The participants were asked to have a household member (spouse, next of kin) to complete a control questionnaire. For an English translation of the questionnaires see Supplementary Materials. This article is protected by copyright. All rights reserved Statistical differences between paired data, e.g. patients and controls, were analyzed using the Wilcoxon Signed-Rank test for continuous and ordinal data or the McNemar test for nominal data. Statistical differences between unpaired data, e.g. organ transplant candidates and recipients, were assessed using the Mann-Whitney-U test for continuous or ordinal data and Fisher's Exact test for nominal data. Correlations between the baseline characteristics and the items on the five-live Likert scale were assessed using Spearman's non-parametric correlation. Statistical analysis was performed using SPSS versions 16 and 26 (IBM Inc, Armonk, NY). Data visualization was performed using Prism 6 (GraphPad Software, LaJolla, CA). P-value <0.05 in two-sided tests was considered statistically significant. We did not correct for multiple comparisons. Items with missing data were removed from the respective analysis. The questionnaire was sent out to 948 patients including 725 SOT recipients and 223 patients on the waiting list. Overall, 481 (51%) patients returned the questionnaire in time. After excluding patients who did not specify pre-or post transplantation state, 365 organ transplant recipients, 112 transplant candidates, and 394 matched household controls were analyzed. Ninety-five percent of patients returning the questionnaire were liver transplant recipients or candidates. The majority of patients were male and the majority of immediate household contacts were female, suggesting that the spouse answered the questionnaire in the majority of controls ( Table 1 ). In organ transplant recipients the most frequent liver disease was alcoholic liver disease (ALD) followed by NAFLD and "other or cryptogenic" liver disease comprising "hepatocellular carcinoma" and "cirrhosis of the liver" without further specification of liver disease by the patients. In patients on the waiting list, ALD was the most frequent diagnosis (47 patients, 45%). Comorbidities are provided in Table 1 . This article is protected by copyright. All rights reserved The median time since transplantation was 6 years (interquartile range 2-9). Eighty-five percent of transplant recipients reported calcineurin inhibitors, 21% mTOR inhibitors, 28% mycophenolate mofetil, and 19% steroids being part of immunosuppression. Thirty percent received dual immunosuppression and 12% triple immunosuppression. Exposure and behavioral changes associated with COVID-19 Seven (1.5%) patients and 10 (2.5%) household controls had contact to confirmed COVID-19 cases. Only one liver transplant recipient reported to be tested positive for SARS-CoV-2 (Table 1) . Seventy-nine percent the organ transplant recipients and 72% of organ transplant candidates "rather agreed" or "agreed" to leave the house less frequent than before the COVID-19 pandemic. This was significantly higher than in controls (58% and 59%, respectively) (Supplementary Table S1 ). The majority of patients and controls reported to wear gloves and/or facemask when leaving the house without statistical differences between organ transplant recipients (78%) and patients on the waiting list (70%, p=0.10). However, organ transplant recipients used personnel protective equipment significantly more frequently than their controls (64%, p=0.004). The vast majority of patients and controls reported to wash their hands more frequently than before the COVID-19 pandemic, reaching from 93% in organ transplantrecipients and patients on the waiting list to 99% in household-controls of waiting-list patients (Table 1) . One liver transplant recipient reported to have unadvisedly reduced immunosuppressive therapy. The majority of patients felt informed about COVID-19. About 80% of patients and controls reported to "agree" or "rather agree" in response to the item "I feel sufficiently informed about the Coronavirus Pandemic" without any differences between the groups. In contrast, only about 60% of patients and controls reported to be sufficiently informed about the influence of the Table S1 ). This article is protected by copyright. All rights reserved Responding to the item "I am afraid to become infected with the Coronavirus", SOT recipients reported a significantly greater fear of being infected with SARS-CoV-2 than their household controls ( Figure 1A and Supplementary Table S1). The fear that the transplant recipient becomes infected with SARS-CoV-2 reported by the household controls (87% "agree" or "rather agree") was significantly higher than the fear reported by the transplant recipient (65%, p<0.001). This pattern was also observed in transplant candidates (56%) and their controls (75%, p=0.008, Figure 1A ). When asked about whether being afraid of becoming infected when visiting different locations, there were no differences between shopping (62% "agree" or "rather agree"), medical offices (64%), and the hospital (63%) in organ transplant recipients. In candidates on the waiting list, the reported fear of a possible infection was highest while shopping (66%) as compared to a medical office (56%) or the hospital (59%). In organ transplant candidates, the difference in Likert scales to the items "I am afraid to become infected in a medical office" and "I am afraid to become infected while shopping" was statistically significant (p=0.04) (Figure 1B and Supplementary Table S1 ). Only a minority of patients after organ transplantation (18%) and on the waiting list (10%) agreed to the item "I experience worse medical care than before the COVID-19 pandemic" (Figure 1C ). A total of 232 (64%) SOT recipients (64%) and 61 (54%) SOT candidates "agreed" or "rather agreed" to the item "I am afraid to become infected with the Coronavirus". Organ transplant recipients reporting fear were more often female (43 vs. 30%, p=0.02), more often received steroid therapy (23% vs. 12%, p=0.01), and more often reported the local newspaper as a primary source of information about the SARS-CoV-2 pandemic (35% vs. 24%, p=0.03) than transplant recipients not reporting fear (Supplementary This article is protected by copyright. All rights reserved 1.09-2.97, p=0.03) were independent indicators of fear of being infected with SARS-CoV-2 in multivariable analysis ( Table 2) . Age, educational status, underlying liver disease, smoking, and influenza vaccination status did not significantly differ between patients reporting versus not reporting fear of becoming infected with SARS-CoV-2 (Supplementary Table S2) . As a consequence, patients reporting fear of becoming infected with COVID-19 more often used personal protective equipment (85% vs. 66%, p<0.001) and washed their hands more frequently (95% vs. 88%, p=0.02). Transplant recipients reporting fear were more likely to skip or postpone scheduled medical visits (52% vs. 29%, p<0.001) and prefer video or phone consultations (51% vs. 21%, p<0.001) (Supplementary Table S2 ). behavior In SOT recipients, older age was correlated with higher agreement to the items "I feel sufficiently informed about the Coronavirus Pandemic" and "I feel sufficiently informed about the influence of the Coronavirus on chronic diseases and transplanted patients", and higher disagreement to the item "I am afraid that my medication could worsen an infection with the Coronavirus" ( Table 3 ). In contrast, shorter duration since transplantation was associated with higher agreement to the items "I am afraid that my medication could worsen an infection with the Coronavirus", "I am afraid to become infected while shopping", and "I leave the house less frequently than my partner/household members". A higher level of immunosuppression, as assessed by the number of immunosuppressant classes used, also correlated with higher agreement to the items "I am afraid that my medication could worsen an infection with the Coronavirus", "I am afraid to become infected in a medical office", "I leave the house less frequently than my partner/household members", and "I did not attend scheduled visits due to the Coronavirus Pandemic" and higher disagreement to the item "I feel sufficiently informed about the influence of the Coronavirus on chronic diseases and transplanted patients" ( Table 3) . This article is protected by copyright. All rights reserved While there is an ongoing debate, to what extent patients with liver disease and after liver transplantation are at increased risk of SARS-CoV-2 infection and COVID-19 complications, it's already foreseeable that the SARS-CoV-2 pandemic will have a long-lasting impact on the medical care of patients with liver disease 14, 16 . One of the central emotional responses during a pandemic is fear and even in non-infected households, the pandemic may act as a major stressor facilitating chronic anxiety 17 . Here we demonstrate that fears associated with the SARS-CoV-2 pandemic are frequently expressed by liver transplantation recipients and candidates as well as by their household members. Transplant recipients who reported fear of infection adhered to washing hands and wearing facemasks and/or gloves when leaving the house. Being afraid of becoming infected with SARS-CoV-2 after transplantation was more frequently reported in female patients and in patients with more intense immunosuppression, i.e. steroids or triple immunosuppression. Notably, the fear of infection was not associated with established risk factors for mortality in COVID-19, such as cardiovascular and pulmonary comorbidity and older age 7 . Despite reports about higher mortality of COVID-19 in patients after SOT 11, 12, 18, 19 , there is no conclusive evidence for a causative role of immunosuppression, yet. As a result, current guidelines recommend continuation of immunosuppressive therapy in transplant patients 14, 20 . Accordingly, only one patient in this survey reported a reduction of tacrolimus without consulting a physician. However, the fear that their medication could worsen an infection with SARS-CoV-2 was expressed by one third of patients after transplantation. This fear was highest in younger patients, patients with a shorter time since transplantation and a more intense immunosuppression in our survey. Notably, such patients were also more likely to report that they do not feel sufficiently informed about the influence of the virus on chronic diseases, underlining the need for better communication strategies in these vulnerable patients. Only 15% of patients stated the transplant center being a relevant source of information about COVID-19. The major given reason was not to steal staff's time. Therefore, contacting patients directly by This article is protected by copyright. All rights reserved sending out information and encouraging them to approach the transplant center with further questions seems advisable. The fear of getting infected with SARS-CoV-2 was higher in patients with more intense immunosuppression. A correlation of severity of immunosuppression and fear of infection has been observed in patients with inflammatory bowel disease (Grunert et al., unpublished) . Weighing benefits against possible harms resulted in a high adherence to the therapy, as only one patient reported a reduction of tacrolimus without consulting a physician. Another important finding of this study is that patients expressed comparable levels of fear contracting COVID-19 in medical facilities being similar to that of shopping areas. Implementing and communicating measures to ensure that hospitals and medical offices are a low risk environment for contracting COVID-19 may improve patients' sense of security. In addition, regular screening of staff and patients may help to detect or prevent outbreaks and identify infected patients early. In some regions of heavily affected countries, intensive care capacities are overloaded with ventilated patients and therefore capacities for organ donation and transplantation are reduced 21, 22 . In addition, routine consultations are cancelled or postponed resulting in a less frequent contact of patients to the healthcare system. In our survey, 44% of the patients reported postponed clinical visits. This may be underestimating the true frequency given the short period between the begin of the pandemic and conducting the survey. It is likely that the proportion of postponed visits will increase over time. One solution may be health care delivery by telehealth in transplant recipients and candidates. 23 In our study, transplanted patients who expressed higher fear of becoming infected with SARS-CoV-2 more often reported that they also postponed scheduled visits at the outpatient clinic and expressed their preference for video or telephone visits. While fears and concerns associated with the SARS-CoV-2 pandemic are frequently expressed by SOT recipients and candidates, measures to prevent infection were frequently followed in the vast majority of patients. Despite the large sample size and the bicenter nature of the survey, there are some limitations. We used 5-point Likert scales as a standard ordinal psychometric measurement of attitudes, This article is protected by copyright. All rights reserved beliefs and opinions. Despite the high response rate, non-response bias, acquiescence, and social desirability may result in overestimation of the adherence to preventive measures und underestimation of the reported reduction in immunosuppression. We tried to minimize possible bias (order effect, acquiescence bias, central tendency, and pattern answering) by comparing the results to matched control groups. However, caution is advised, when transferring these results to SOT recipients other than liver and pancreas/kidney or patients receiving more intensified immunosuppression. Differences in national health services as well as cultural differences between different populations need to be taken into account when interpreting and generalizing these results. The current COVID-19 pandemic is a highly dynamic process, and recommendations and regulations change rapidly. As fear is usually highest at the beginning of a new threat, it is likely that the responses underlie dynamic changes as well. The incidence of COVID-19 in Germany is still low, therefore, only a minority of the participants had contact to confirmed cases of COVID-19. Based on the fears and information deficits reported by patients in this survey, transplant centers are advised to intensify communication strategies and consider implementing telehealth in order to provide optimum medical care in liver transplant recipients and patients on the waiting list. PAR and AS conceived of the study. PAR, FR, SA, and TB recruited patients and collected the data. TB performed statistical analysis. PAR and TB wrote the manuscript. CT, US, and SA gave important intellectual input in data interpretation. All authors read and approved the final version of the manuscript. Funding was not obtained for this study. (20) 156 (44) 27 (8) 97 (28) n=293 58 (20) 120 (41) 41 (11) 74 ( This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved A Novel Coronavirus from Patients with Pneumonia in China WHO Director-General's opening remarks at the media briefing on COVID-19 -11 Johns Hopkins Coronavirus Resource Center COVID-19 and the policy sciences: initial reactions and perspectives Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study Accepted Article This article is protected by copyright. All rights reserved COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet Liver injury in COVID-19: management and challenges COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy Determining risk factors for mortality in liver transplant patients with COVID-19 Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper Highlights for management of patients with Autoimmune Liver Disease during COVID-19 pandemia COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav COVID-19 in solid organ transplant recipients: a single-center case series from Spain COVID-19 in posttransplant patients-report of 2 cases Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy Early Impact of COVID-19 on Transplant Center Practices and Policies in the United States Use of Telehealth Expedites Evaluation and Listing of Patients Referred for Liver Transplantation Accepted Article Coefficients from Spearman's non-parametric correlation with five level Likert-scales shown * P< 0.05; ** P<.0.01.